Clinical TrialsSearch results
Number of results: 738
Other
- A randomized, double-blind, phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for metastatic HER2+ breast cancer
- metastatic HER2+ breast cancer
- Nakamura Yoshinobu
- 2022-05-28
Other
- A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease
- Parkinson's disease
- Department of neurology, Fukushima medical university
- 2008-12-17
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- A randomized, parallel-group, multicenter clinical trial to evaluate the preventive effect on acute exacerbation of chronic obstructive pulmonary disease (COPD) with Carbocisteine (1500mg/day)
- COPD
- Department of Respiratory Medicine Juntendo University, School of Medicine
- 2006-12-01
Other
- A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease
- Inherited Mitochondrial Disease
- Vinay Penematsa
- 2023-11-05
Recruiting
- A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
- Systemic Lupus Erythematosus
- Ranganathan Usha
- 2022-02-05
Other
- A study for evaluation of AHCC(R) on eradication of Human papillomavirus
- Positive cytodiagnosis, positive for high-risk HPV
- Watari Hidemichi
- 2019-03-19
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Completed
- A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants with Moderate to Severe Atopic Dermatitis
- Dermatitis, Atopic
- Nishikawa Kazuko
- 2021-04-28
Recruiting
- A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA versus VRd followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
- Multiple Myeloma
- Fujikawa Ei
- 2021-07-30